Insider trades

Acorn Bioventures, 10% Owner of OnKure Therapeutics OKUR, has filed 2 purchases and 0 sales on the open market. The latest trade was on 25/05/15.

Acorn Bioventures

10% Owner
First filing
25/05/19
Trades
2 trades
Buys / sales
2 / 0
12-month net buying
No record
Last trade
25/05/15

Trading activity

Transactions

Trade type
OKUR
Open-market buy25/05/1525/05/191,400,000 sh2 trades$1.85avg.$2,590,000No record